In summary, the present study provides first evidence that HHV-8 seropositivity is associated with increased odds of prostate cancer in men harboring the IFNL4 rs368234815-ΔG germline variant, consistent with previous data from this group. The gene discussed is IFNL4; the disease is prostate carcinoma.